| |
|
|
|
Alpine Immune Sciences- Inc.  
|
|
6.85 -0.14 (-0.02%) |
08-14 16:00 |
|
Open: |
7.04 |
Pre close: |
6.99 |
Target:
|
9.22
|
|
High: |
7.28 |
Low: |
6.835 |
Resistance:
|
7.89
8.59
|
|
Volume: |
17,961 |
Market Cap: |
95M |
Support:
|
6.77
5.63
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.90
 |
MACD |
MACD(12,26):
|
-0.35 |
|
MA(20): |
7.50  |
Signal(12,26,9): |
-0.31 |
|
MA(100): |
8.07 |
Stochastic Oscillator |
%K(14,3):
|
10.07 |
|
MA(250): |
9.40 |
%D(3): |
8.97 |
|
Average Volume(K) |
3-Month: |
1677
|
52-Week |
High:
|
12.87 |
|
10-Days: |
1370 |
Low: |
6.77 |
|
RSI |
RSI(14):
|
33.43 |
Change(%): |
-17.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.470 |
Return on Equity (ttm) |
-18.0 |
Shares Out. (M) |
13.85 |
|
EPS Est. Current Year |
-3.180 |
Return on Assets (ttm) |
-16.6 |
Shares Float (M) |
13.68 |
|
EPS Est. Next Year |
-2.500 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.30 |
|
EPS Est. Next Quarter |
-1.030 |
Qtrly Rev. Growth |
-57.3 |
% Held by Institutions |
68.00 |
|
Forward EPS |
-2.604 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
39 |
|
Book Value (p.s.) |
1.320 |
EBITDA (p.s.) |
0.163 |
P/E |
-4.66 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
5.19 |
|
Profit Margin |
-22.63 |
Operating Cash Flow
(M) |
-18.84 |
P/S |
729788416.00 |
|
Operating Margin |
-1325.06 |
Levered Free Cash Flow
(M) |
-12.01 |
P/CF |
-5.04 |
|
|
|
|
|
|
